Invention Application
- Patent Title: PYRROLOPYRIDAZINE INHIBITORS OF IRAK4 ACTIVITY
-
Application No.: US15557201Application Date: 2016-03-07
-
Publication No.: US20180051029A1Publication Date: 2018-02-22
- Inventor: JONGWON LIM , MICHAEL D. ALTMAN , JASON D. BRUBAKER , CRAIG R. GIBEAU
- Applicant: JONGWON LIM , MICHAEL D. ALTMAN , JASON D. BRUBAKER , CRAIG R. GIBEAU , MERCK SHARP & DOHME CORP.
- Applicant Address: US NJ RAHWAY
- Assignee: MERCK SHARP & DOHME CORP.
- Current Assignee: MERCK SHARP & DOHME CORP.
- Current Assignee Address: US NJ RAHWAY
- International Application: PCT/US16/21121 WO 20160307
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K45/06 ; A61K31/5025 ; C07D519/00 ; A61K31/551 ; A61K31/55
Abstract:
The present invention relates to pyrrolopyridazine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
Public/Granted literature
- US10040798B2 Pyrrolopyridazine inhibitors of IRAK4 activity Public/Granted day:2018-08-07
Information query
